Good news! Google is getting better at serving up results that you actually care about. The bad news? If you haven’t adapted your website for mobile viewing, you are likely […]

For the first time in more than 50 years of surveys, the CDC on Wednesday reported that more than 90% of Americans — 90.8% of us, to be specific — have […]

Immunotherapy is being hailed as the future of cancer treatment. Harnessing the body’s own immune system to attack and kill cancer cells, immunotherapy is a burgeoning field of medicine that […]

Humira

Humira during 2014 remained the world’s best-selling prescription medicine; Sovaldi vaulted into second place in its first full year on the market; Harvoni is challenging Humira for the 2015 sales crown.

For a listing of the top 200 prescription medicines ranked by 2014 sales, please click on the link below: Top 200 Medicines Online 0815

Not your father’s launches The leading members of the pharmaceutical industry’s new compound class of 2013 have set a new standard for launch success.   Remember when a drug that […]

For a listing of the new molecular entity U.S. launches during 2013, please click on the link below: NME 2013 Launches Online 0815

Still no Rx for patient adherence Pharma limited in what it can do, but can still have a positive impact   Patient adherence remains a complex puzzle with no simple […]

By Howard Brock — Howard Brock is head of commercial models and local market strategy for Campbell Alliance. Additional contributors include Renee Selman, president, patient outcomes, Adheris Health; Andrew Aromando, […]

How Europe is turning transparency reporting from business constraint into commercial advantage By Tim Slevin and Guillaume Roussel — Tim Slevin is senior VP of global data solutions and Guillaume […]